Looking at the Peanut Allergy Landscape After Potentially the First FDA Approved TreatmentsTicker(s): AIMT, DBVT
Someone with experience from clinical trials with both DBVT and AIMT's products as well as a significant number of peanut allergy patients.
The conversation specifics will become more detailed one label and feedback becomes available, but the thrust of the conversation will be on the Peanut Allergy Landscape in late 2019.
197Days Left to Join Project
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.